These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9714304)

  • 1. Restoration of hepatic cytochrome c oxidase activity and expression with acetyl-L-carnitine treatment in spf mice with an ornithine transcarbamylase deficiency.
    Mawal YR; Rama Rao KV; Qureshi IA
    Biochem Pharmacol; 1998 Jun; 55(11):1853-60. PubMed ID: 9714304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive decrease of cerebral cytochrome C oxidase activity in sparse-fur mice: role of acetyl-L-carnitine in restoring the ammonia-induced cerebral energy depletion.
    Rao KV; Mawal YR; Qureshi IA
    Neurosci Lett; 1997 Mar; 224(2):83-6. PubMed ID: 9086462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition by hyperammonemia of the electron transport chain enzymes in synaptosomes and non-synaptic mitochondria in ornithine transcarbamylase-deficient spf-mice: restoration by acetyl-L-carnitine.
    Qureshi K; Rao KV; Qureshi IA
    Neurochem Res; 1998 Jun; 23(6):855-61. PubMed ID: 9572674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic mitochondrial proteins in congenitally hyperammonemic spf mice: effect of acetyl-L-carnitine.
    Benzerrouk R; Qureshi IA
    Biosci Biotechnol Biochem; 2001 Mar; 65(3):495-500. PubMed ID: 11330659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in the MK-801 binding sites of the NMDA sub-type of glutamate receptor in a mouse model of congenital hyperammonemia: prevention by acetyl-L-carnitine.
    Rao KV; Qureshi IA
    Neuropharmacology; 1999 Mar; 38(3):383-94. PubMed ID: 10219976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Metabolism; 1993 Aug; 42(8):1039-46. PubMed ID: 8102193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental deficiency of the cholinergic system in congenitally hyperammonemic spf mice: effect of acetyl-L-carnitine.
    Ratnakumari L; Qureshi IA; Maysinger D; Butterworth RF
    J Pharmacol Exp Ther; 1995 Jul; 274(1):437-43. PubMed ID: 7616428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency.
    Zimmer KP; Bendiks M; Mori M; Kominami E; Robinson MB; Ye X; Wilson JM
    Mol Med; 1999 Apr; 5(4):244-53. PubMed ID: 10448647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Biochem Pharmacol; 1993 Jan; 45(1):137-46. PubMed ID: 8424807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compared expression levels of ornithine transcarbamylase and carbamylphosphate synthetase in liver and small intestine of normal and mutant mice.
    Dubois N; Cavard C; Chasse JF; Kamoun P; Briand P
    Biochim Biophys Acta; 1988 Sep; 950(3):321-8. PubMed ID: 3167057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of congenital hyperammonemia on the cerebral and hepatic levels of the intermediates of energy metabolism in spf mice.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Biochem Biophys Res Commun; 1992 Apr; 184(2):746-51. PubMed ID: 1575747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes.
    Marini JC; Erez A; Castillo L; Lee B
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1764-71. PubMed ID: 17925451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute metabolic decompensation due to influenza in a mouse model of ornithine transcarbamylase deficiency.
    McGuire PJ; Tarasenko TN; Wang T; Levy E; Zerfas PM; Moran T; Lee HS; Bequette BJ; Diaz GA
    Dis Model Mech; 2014 Feb; 7(2):205-13. PubMed ID: 24271778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental study of hepatic glutamine synthetase in a mouse model of congenital hyperammonemia.
    Skarpetas A; Mawal Y; Qureshi IA
    Biochem Mol Biol Int; 1997 Sep; 43(1):133-9. PubMed ID: 9315291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrations of ammonia metabolism in ornithine carbamoyltransferase-deficient spf-ash mice and their prevention by treatment with urea cycle intermediate amino acids and an ornithine aminotransferase inactivator.
    Li MX; Nakajima T; Fukushige T; Kobayashi K; Seiler N; Saheki T
    Biochim Biophys Acta; 1999 Sep; 1455(1):1-11. PubMed ID: 10524224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient hyperammonemia during aging in ornithine transcarbamylase-deficient, sparse-fur mice.
    Gushiken T; Yoshimura N; Saheki T
    Biochem Int; 1985 Nov; 11(5):637-43. PubMed ID: 4091843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.
    Imoto K; Tanaka M; Goya T; Aoyagi T; Takahashi M; Kurokawa M; Tashiro S; Kato M; Kohjima M; Ogawa Y
    BMC Gastroenterol; 2022 Mar; 22(1):144. PubMed ID: 35346058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive characterization of ureagenesis in the spf
    Allegri G; Deplazes S; Rimann N; Causton B; Scherer T; Leff JW; Diez-Fernandez C; Klimovskaia A; Fingerhut R; Krijt J; Kožich V; Nuoffer JM; Grisch-Chan HM; Thöny B; Häberle J
    J Inherit Metab Dis; 2019 Nov; 42(6):1064-1076. PubMed ID: 30714172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of various inhibitors on the regulation of orotic acid excretion in sparse-fur mutant mice (spf/Y) deficient in ornithine transcarbamylase.
    Nelson J; Qureshi IA; Vasudevan S; Sarma DS
    Chem Biol Interact; 1993 Oct; 89(1):35-47. PubMed ID: 8221965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of ornithine transcarbamylase deficiency in spf and spf-ash mutant mice.
    Ohtake A; Takayanagi M; Yamamoto S; Kakinuma H; Nakajima H; Tatibana M; Mori M
    J Inherit Metab Dis; 1986; 9(3):289-91. PubMed ID: 3099076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.